98 related articles for article (PubMed ID: 8315331)
1. [Spinocerebellar degeneration].
Takayanagi T
Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):377-80. PubMed ID: 8315331
[No Abstract] [Full Text] [Related]
2. Bedside and electro-oculographic analysis of abnormal ocular movements in spinocerebellar degenerations: effects of thyrotropin-releasing hormone.
Yamamoto H; Saito S; Sobue I
Neurology; 1988 Jan; 38(1):110-4. PubMed ID: 3122069
[TBL] [Abstract][Full Text] [Related]
3. [Spinocerebellar degeneration and neuropeptides].
Matsuoka Y; Sakurai N
Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1705-8. PubMed ID: 2516527
[No Abstract] [Full Text] [Related]
4. [Analysis of follow-up survey in spinocerebellar degeneration].
Yanagimoto S; Takayanagi T; Iizuka R; Sobue I
Rinsho Shinkeigaku; 1989 Feb; 29(2):138-46. PubMed ID: 2752638
[TBL] [Abstract][Full Text] [Related]
5. The long loop reflex in spinocerebellar degeneration and motor neuron disease--its changes with TRH therapy.
Touge T; Takeuchi H; Yamada A; Miki H; Nishioka M
Electromyogr Clin Neurophysiol; 1990; 30(3):131-40. PubMed ID: 2112456
[TBL] [Abstract][Full Text] [Related]
6. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
Izumi Y; Fukuuchi Y; Ishihara N; Imai A; Komatsumoto S
Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations and thyrotropin releasing hormone therapy in cerebellar degenerations.
Wang HC; Chiu HC
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Mar; 47(3):161-8. PubMed ID: 1848143
[TBL] [Abstract][Full Text] [Related]
8. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
Arai M
Rinsho Shinkeigaku; 1988 Jun; 28(6):595-604. PubMed ID: 2466598
[No Abstract] [Full Text] [Related]
9. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
Filla A; De Michele G; Di Martino L; Mengano A; Iorio L; Maggio MA; Campanella G
Riv Neurol; 1989; 59(2):83-8. PubMed ID: 2505370
[TBL] [Abstract][Full Text] [Related]
10. [Alteration of CBF and CMRO2 and TRH effects on CBF in spinocerebellar degeneration. The positron emission tomography study].
Harada K; Fukuyama H; Miyoshi T; Namura Y; Kameyama M
Rinsho Shinkeigaku; 1988 May; 28(5):563-8. PubMed ID: 3145826
[No Abstract] [Full Text] [Related]
11. Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.
Sobue I; Yamamoto H; Konagaya M; Iida M; Takayanagi T
Lancet; 1980 Feb; 1(8165):418-9. PubMed ID: 6101863
[No Abstract] [Full Text] [Related]
12. Motor evoked potentials in the spinocerebellar ataxias type 1 and type 3.
Schöls L; Amoiridis G; Langkafel M; Schöls S; Przuntek H
Muscle Nerve; 1997 Feb; 20(2):226-8. PubMed ID: 9040663
[No Abstract] [Full Text] [Related]
13. Acute and chronic effects of thyrotropin-releasing hormone (TRH) on stabilogram in spinocerebellar degenerations.
Yoshida M; Nakanishi T; Komatsu Y
Tohoku J Exp Med; 1986 Mar; 148(3):327-31. PubMed ID: 3085285
[TBL] [Abstract][Full Text] [Related]
14. Neuro-otological findings of spinocerebellar degeneration with slow eye movement.
Komatsuzaki A
Adv Otorhinolaryngol; 1983; 30():214-6. PubMed ID: 12325188
[No Abstract] [Full Text] [Related]
15. [Spinocerebellar degeneration].
Sugai Y
Ryoikibetsu Shokogun Shirizu; 2003; (40):272-4. PubMed ID: 14626118
[No Abstract] [Full Text] [Related]
16. [Etiology and physiopathology of hereditary spinocerebellar degeneration].
Tsuji S
Nihon Naika Gakkai Zasshi; 2001 Sep; 90(9):1872-6. PubMed ID: 11681074
[No Abstract] [Full Text] [Related]
17. [Abnormal ocular movements in spinocerebellar degenerations].
Yamamoto H
No To Shinkei; 1995 Jan; 47(1):23-33. PubMed ID: 7669398
[No Abstract] [Full Text] [Related]
18. [Frequency response analysis of oculomotor functions (II)--Comparative study of Parkinson's disease with spinocerebellar degeneration and normal control].
Hayashi F; Koike Y; Hibino R; Sakurai N; Sobue I
Rinsho Shinkeigaku; 1986 Jul; 26(7):665-72. PubMed ID: 3464377
[No Abstract] [Full Text] [Related]
19. Spinocerebellar degeneration and neuropeptides.
Matsuoka Y; Sakurai N
Jpn J Med; 1989; 28(6):791-3. PubMed ID: 2517445
[No Abstract] [Full Text] [Related]
20. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
Waragai M; Ogawara K; Takaya Y; Hayashi M
Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
